SK75094A3 - Naphthyridine derivatives - Google Patents

Naphthyridine derivatives Download PDF

Info

Publication number
SK75094A3
SK75094A3 SK750-94A SK75094A SK75094A3 SK 75094 A3 SK75094 A3 SK 75094A3 SK 75094 A SK75094 A SK 75094A SK 75094 A3 SK75094 A3 SK 75094A3
Authority
SK
Slovakia
Prior art keywords
group
formula
alkyl
carbon atoms
hydrogen atom
Prior art date
Application number
SK750-94A
Other languages
English (en)
Slovak (sk)
Inventor
Bernard J Armitage
John G Bowen
Malcolm J Grossley
Ian M Hunneyball
Bruce W Leslie
Thomas K Miller
Michael Spowage
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of SK75094A3 publication Critical patent/SK75094A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK750-94A 1991-12-23 1992-12-12 Naphthyridine derivatives SK75094A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
PCT/EP1992/002901 WO1993013097A1 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (1)

Publication Number Publication Date
SK75094A3 true SK75094A3 (en) 1995-04-12

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
SK750-94A SK75094A3 (en) 1991-12-23 1992-12-12 Naphthyridine derivatives

Country Status (22)

Country Link
US (1) US5464781A (fi)
EP (1) EP0618916B1 (fi)
JP (1) JP2527917B2 (fi)
CN (1) CN1096784A (fi)
AT (1) ATE171452T1 (fi)
AU (1) AU656832B2 (fi)
BG (1) BG98813A (fi)
CA (1) CA2125858A1 (fi)
CZ (1) CZ153594A3 (fi)
DE (1) DE69227125T2 (fi)
FI (1) FI943019A0 (fi)
GB (1) GB9127252D0 (fi)
HR (1) HRP921455A2 (fi)
HU (1) HUT66971A (fi)
IL (1) IL104169A0 (fi)
IN (1) IN174405B (fi)
MX (1) MX9207494A (fi)
NO (1) NO942376L (fi)
NZ (1) NZ246156A (fi)
SI (1) SI9200408A (fi)
SK (1) SK75094A3 (fi)
WO (1) WO1993013097A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
KR100567649B1 (ko) * 1996-09-25 2006-04-05 아스트라제네카 유케이 리미티드 혈관 내피 성장 인자와 같은 성장 인자의 효과를 억제하는 퀴놀린 유도체
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
WO2001004111A1 (en) 1999-07-09 2001-01-18 Glaxo Group Limited Anilinoquinazolines as protein tyrosine kinase inhibitors
MXPA02009891A (es) 2000-04-07 2003-03-27 Astrazeneca Ab Compuestos de quinazolina.
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US7618975B2 (en) 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
CN1890234A (zh) 2003-12-23 2007-01-03 辉瑞大药厂 新颖的喹啉衍生物
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
EP2345652A1 (en) 2005-12-21 2011-07-20 Abbott Laboratories Antiviral compounds
ATE541844T1 (de) * 2005-12-21 2012-02-15 Abbott Lab Antivirale verbindungen
RU2467007C2 (ru) 2005-12-21 2012-11-20 Эбботт Лэборетриз Производные [1,8]нафтиридина, полезные в качестве ингибиторов репликации вируса hcv
TW200738707A (en) * 2005-12-21 2007-10-16 Abbott Lab Anti-viral compounds
ES2395386T3 (es) * 2005-12-21 2013-02-12 Abbott Laboratories Compuestos antivirales
CA2672737A1 (en) 2006-12-20 2008-11-06 Abbott Laboratories Anti-viral compounds
US20110269758A1 (en) * 2008-07-03 2011-11-03 Merck Patent Gmbh Naphthyridinones as protein kinase inhibitors
WO2010097410A1 (en) 2009-02-24 2010-09-02 Respiratorius Ab Novel bronchodilating diazaheteroaryls
WO2011063398A1 (en) * 2009-11-23 2011-05-26 Cylene Pharamaceuticals, Inc. Polymorphs and salts of a kinase inhibitor
PE20130211A1 (es) 2010-04-02 2013-03-22 Senomyx Inc Modificador del sabor dulce

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
WO1986006718A1 (en) * 1985-05-17 1986-11-20 The Australian National University Antimalarial compounds
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc p−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
WO1989000571A2 (en) * 1987-07-22 1989-01-26 Schering Corporation Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 1,8−ナフチリジン−2−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
EP0618916B1 (en) 1998-09-23
FI943019A (fi) 1994-06-22
HUT66971A (en) 1995-01-30
HU9401877D0 (en) 1994-09-28
HRP921455A2 (en) 1994-12-31
AU656832B2 (en) 1995-02-16
ATE171452T1 (de) 1998-10-15
FI943019A0 (fi) 1994-06-22
CA2125858A1 (en) 1993-07-08
DE69227125T2 (de) 1999-02-18
AU3158793A (en) 1993-07-28
JP2527917B2 (ja) 1996-08-28
NZ246156A (en) 1996-01-26
DE69227125D1 (de) 1998-10-29
NO942376D0 (fi) 1994-06-22
IN174405B (fi) 1994-11-26
JPH07502280A (ja) 1995-03-09
BG98813A (bg) 1995-05-31
NO942376L (no) 1994-06-22
GB9127252D0 (en) 1992-02-19
US5464781A (en) 1995-11-07
IL104169A0 (en) 1993-05-13
MX9207494A (es) 1993-07-01
EP0618916A1 (en) 1994-10-12
CN1096784A (zh) 1994-12-28
CZ153594A3 (en) 1995-02-15
SI9200408A (en) 1993-09-30
WO1993013097A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
SK75094A3 (en) Naphthyridine derivatives
US5780482A (en) Condensed 4-aminopyridines with antirheumatic activity
US4753951A (en) Condensed imidazopyridine derivatives useful as psychotropic agents
KR900007780B1 (ko) 축합된 피롤리논 유도체의 제조방법
UA74850C2 (en) Amide derivatives as nmda receptor antagonists
HUT77348A (hu) Tienopiridin- és tienopirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
CZ374692A3 (en) Proteolytic enzymes inhibitors based on saccharin derivatives
CZ289573B6 (cs) Sacharinové deriváty, farmaceutický prostředek obsahující tyto deriváty a pouľití těchto sacharinových derivátů
SK280822B6 (sk) Imidazopyridíny, spôsob ich prípravy, farmaceutické prostriedky s ich obsahom a ich použitie
HU198047B (en) Process for production of new condensated derivatives of pirrol and medical preparatives containing these compounds as active substances
JP4227197B2 (ja) 1H―ピリド[3,4―b]インドール―4―カルボキサミド誘導体、その製造および治療上の適用
WO1998009960A1 (fr) Derives de pyrimidine 2,4-bisubstitues, procede pour leur production et compositions medicales les contenant
JP4248245B2 (ja) 6−フェニルベンゾナフチリジン
US4778801A (en) Isoindolinone derivatives, production and use thereof
JPS6377856A (ja) 新規なフェニル、ピロリジン―2―イル置換5員複素環化合物およびその製造方法並びにこの化合物を有効成分とする抗精神病医薬組成物
NZ203217A (en) Pyridobenzodiazepinone derivatives and pharmaceutical compositions
US5102890A (en) Pyrrole derivatives, their preparation and pharmaceutical compositions which contain them
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置2で置換された4―ohキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
CZ23799A3 (cs) Farmaceutický přípravek obsahující 5HT2C antagonistu a D2 antagonistu
JPS61205275A (ja) 新規の8‐チオテトラヒドロキノリン誘導体及びそれらの塩
JPH08225531A (ja) キノリンまたはキナゾリン誘導体を含んでなる医薬およびそれに用いる新規誘導体
WO1995007909A1 (en) Alkyl-1-alkyl-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxylates as anti-rheumatic agents
JPH11279157A (ja) バルビツール酸誘導体およびそれらからなる骨・軟骨疾患予防・治療薬
JPS60100570A (ja) 新規フラボン誘導体
JPH04103572A (ja) 4―フェニル―2―(1―ピペラジニル)ピリジン誘導体